medline.ch Respirationstrakt Neoplasie

	Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming. Signal Transduct Target Ther Zhou L, Liu Y, Xing Z, Wu Y, Yang X, Chen S, Kang K, Wang M, Zhou Z, Huang M, Gong Y, Zhou L, Zhou X, Li J, Yao Z, Zheng Q, Kong FS, Niedermann G, Luo R, Lu Y, Xue J. PMID: 42091852 [PubMed - indexed for MEDLINE]
	The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges. Discov Oncol Song C, Lu DS, Zhao CY, Xu ZY, Peng HJ, Li XL, Zeng HY, Li JH, Guo JJ, Yang N. PMID: 42091781 [PubMed - as supplied by publisher]
	Diagnostic Challenge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Case Requiring Prostate Rebiopsy After an Inconclusive Metastatic Lung Biopsy. Intern Med Nakagaki S, Ito T, Sugiura K, Suzuki H, Morishita T, Taki S, Miyazawa A, Hayashi N, Hibino Y. PMID: 42091458 [PubMed - as supplied by publisher]
	Molecular Pathology of Lung Cancer. Surg Pathol Clin Lingard A, Dacic S. PMID: 42091274 [PubMed - indexed for MEDLINE]
	Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer. JCO Precis Oncol Bansal D, Ponvilawan B, Grachev D, Kushnarev V, Tarasov A, Valiev I, Danilov K, Butusova A, Turova P, Bagaev A, Kotlov N, Al-Obaidi A, Ward C, Subramanian J. PMID: 42090630 [PubMed - indexed for MEDLINE]
	Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review. Target Oncol Goto K, Hayashi H, Maruti SS, Zettl H, Mittal L, Pathak S, Le X. PMID: 42090048 [PubMed - as supplied by publisher]
	Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy. Eur Radiol Kalsi HS, Linton-Reid K, Kim C, Chen M, Crowe V, Alemu E, Mahboobani S, Gibeon D, Procter A, Hajhosseiny M, Owens C, Bartlett EC, Porta N, Thavaraja T, Doran S, Devaraj A, Sharma B, Nair A, Aboagye EO, Lee RW. PMID: 42089967 [PubMed - as supplied by publisher]
	The application and challenges of immune checkpoint inhibitors in lung cancer therapy. Front Immunol Li B, Ren Y, Zhang X. PMID: 42088497 [PubMed - indexed for MEDLINE]
	Efficacy and safety of local consolidative therapy combined with systemic therapy in driver-negative oligometastatic non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol Han H, Li L, Park T, Yang Y, Alai G, Zhong C, Lin Y. PMID: 42088207 [PubMed]
	GCC2 in Small Extracellular Vesicles as a Diagnostic and Prognostic Biomarker of Early-Stage Lung Adenocarcinoma. J Extracell Vesicles Choi BH, An H, Cho S, Lee S, Kim HR, Cho JH, Lee JH, Kim GY, Jeon OH, Shin H, Choi Y, Kim HK. PMID: 42087680 [PubMed - indexed for MEDLINE]
	Radiation-triggered acute exacerbation of progressive fibrotic interstitial lung diseases: 'Are we advancing the frontier or crossing a dangerous line?'. Ther Adv Respir Dis Dimeas IE, Miziou A, Mitchell PD, Daniil Z, McCarthy C. PMID: 42087338 [PubMed - indexed for MEDLINE]
	Clinical validation of a high-definition mid-position magnetic resonance imaging approach for lung radiotherapy planning. Med Phys Keijnemans K, van Lier ALHMW, Borman PTS, Tekatli H, Pomp J, van Weelderen RE, Raaymakers BW, Fast MF. PMID: 42086464 [PubMed - indexed for MEDLINE]
	Brief Report: Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: CALGB 30610 (Alliance) / RTOG 0538. Int J Radiat Oncol Biol Phys Bogart JA, Wang X, Masters G, Komaki R, Gaspar LE, Heymach J, Dobelbower MC, Kuzma C, Waqar SN, Petty W, Stinchcombe TE, Bradley JD, Vokes E. PMID: 42086125 [PubMed - as supplied by publisher]
	Dual immunometabolic regulation and therapeutic targeting of TAMs, microglia and astrocytes in brain metastasis of non-small cell lung cancer. Biochim Biophys Acta Rev Cancer Liu Y, Yang F, Jin Y, Zhang Q, Zhao B, Liang Y, Hou N, Li Q. PMID: 42086087 [PubMed - as supplied by publisher]
	Understanding Public Perceptions of Lung Cancer in China: Infodemiology Study of Baidu Index and Weibo Posts. J Med Internet Res Li Z, Zhang J, Fan Y, Chen N, Liu L. PMID: 42085659 [PubMed - indexed for MEDLINE]
	Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies. J Clin Oncol Willmann J, Dee EC, Hendriks LEL, Dimitriou NM, Jongbloed M, Schoenfeld AJ, Drilon A, Ganesh K, Zhang YH, Feldman J, Werner R, Opitz I, Carrot-Zhang J, Schultz N, Veeraraghavan H, Jones DR, Awad M, Rudin CM, Popat S, De Ruysscher D, Gomez DR, Guckenberger M, Iyengar P. PMID: 42085620 [PubMed - as supplied by publisher]
	A systematic review of radon concentrations and its lung cancer burden in Iran over two decades (2024-2000). Rev Environ Health Borhani Yazdi N, Khanizadeh M, Shamsipour M, Faridi S, Naddafi K, Momeniha F, Hassanvand MS. PMID: 42085588 [PubMed - as supplied by publisher]
	NRT Starter Packs and Gain-Framed Messages to Promote Smoking Cessation in Lung Cancer Screening: A Randomized Trial. Am J Respir Crit Care Med Fucito LM, Rojewski AM, Tanoue L, Bernstein SL, Baker NL, Tanner N, Carpenter MJ, Cummings KM, Silvestri G, Toll BA. PMID: 42085282 [PubMed - as supplied by publisher]
	Impact of Race and Acculturation on Lung Cancer Screening Eligibility: A Multi-Center Lung Cancer Cohort Study. Am J Respir Crit Care Med Choi E, Shusted C, Yang H, Evans H, Katcher J, Shieh Y, Vachani A, Rendle K, Barta JA. PMID: 42085216 [PubMed - as supplied by publisher]
	Expanded detection of early fibrotic phenotypes using lobar traction bronchiolectasis in lung cancer screening. Am J Respir Crit Care Med Cheng DO, Yamada D, Azimbagirad M, Bhamani A, Egashira R, Chapman R, Mccabe J, Wang S, Naftel J, Marguerie S, Wallis T, Dunbar J, Vasudev P, SUMMIT Consortium, Nair A, Alexander DC, Janes SM, Jones MG, Selvarajah B, Jacob J. PMID: 42085205 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 159349

Seite 1 von 7968



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung